These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15153759)

  • 1. Heparin-coated hemodialyzers--the holy grail for patients at risk of bleeding?
    Evenepoel P
    Nephron Clin Pract; 2004; 97(1):c1-2. PubMed ID: 15153759
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding.
    Lee KB; Kim B; Lee YH; Yoon SJ; Kang WH; Huh W; Kim DJ; Oh HY; Kim YG
    Nephron Clin Pract; 2004; 97(1):c5-10. PubMed ID: 15153761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding.
    Pinnick RV; Wiegmann TB; Diederich DA
    N Engl J Med; 1983 Feb; 308(5):258-61. PubMed ID: 6848936
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical usefulness of heparin-coated dialyzers].
    Kopeć J; Sułowicz W
    Przegl Lek; 2014; 71(8):430-2. PubMed ID: 25546914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin free hemodialysis using heparin coated hemophan.
    Mujais SK; Chimeh H
    ASAIO J; 1996; 42(5):M538-41. PubMed ID: 8944937
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
    Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis.
    Laville M; Dorval M; Fort Ros J; Fay R; Cridlig J; Nortier JL; Juillard L; Dębska-Ślizień A; Fernández Lorente L; Thibaudin D; Franssen C; Schulz M; Moureau F; Loughraieb N; Rossignol P
    Kidney Int; 2014 Dec; 86(6):1260-7. PubMed ID: 25007166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin-free hemodialysis in chronic patients for temporary management of conditions with a high risk of bleeding].
    Stradtmann H; Förster S; Jalinski W
    Z Urol Nephrol; 1988 Jul; 81(7):449-53. PubMed ID: 3176720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis without anticoagulants: efficiency and hemostatic aspects.
    Casati S; Moia M; Graziani G; Cantaluppi A; Citterio A; Mannucci PM; Ponticelli C
    Clin Nephrol; 1984 Feb; 21(2):102-5. PubMed ID: 6723110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical consequences of heparin-free hemodialysis.
    McGill RL; Blas A; Bialkin S; Sandroni SE; Marcus RJ
    Hemodial Int; 2005 Oct; 9(4):393-8. PubMed ID: 16219060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two dialysers (AN69ST vs. FX100) for heparin-free dialysis in patients with oral anticoagulation.
    Kodras K; Benesch T; Neumann I; Haas M
    Blood Purif; 2008; 26(3):226-30. PubMed ID: 18305385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
    G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
    Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-coated dialyzer membranes: is non-inferiority good enough?
    Meijers BK; Poesen R; Evenepoel P
    Kidney Int; 2014 Dec; 86(6):1084-6. PubMed ID: 25427085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the editor.
    Polaschegg HD
    J Ren Care; 2009 Jun; 35(2):108. PubMed ID: 19432856
    [No Abstract]   [Full Text] [Related]  

  • 17. A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8).
    Sagedal S; Witczak BJ; Osnes K; Hartmann A; Os I; Eikvar L; Klingenberg O; Brosstad F
    Blood Purif; 2011; 32(3):151-5. PubMed ID: 21659742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
    Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P
    Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reoperative sternotomy: minimizing injury without the risks of systemic heparin.
    Singh AK; Stearns G; Maslow A; Feng WC; Schwartz C
    J Thorac Cardiovasc Surg; 2011 Apr; 141(4):1085; author reply 1085. PubMed ID: 21419908
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac surgery in patients with dialysis-dependent renal disease.
    Suehiro S; Shibata T; Sasaki Y; Murakami T; Hosono M; Fujii H; Kinoshita H
    Ann Thorac Cardiovasc Surg; 1999 Dec; 5(6):376-81. PubMed ID: 10637387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.